APA (7th ed.) Citation

Giesel, F. L., Flechsig, P., Kuder, T. A., Schwartz, L. H., Wulfert, S., Zechmann, C., . . . Kratochwil, C. (2013). Contrast-enhanced ultrasound monitoring of perfusion changes in hepatic neuroendocrine metastases after systemic versus selective arterial 177Lu/90Y-DOTATOC and 213Bi-DOTATOC radiopeptide therapy. Experimental oncology, 35(2), .

Chicago Style (17th ed.) Citation

Giesel, Frederik L., Paul Flechsig, Tristan Anselm Kuder, L. H. Schwartz, Sarah Wulfert, Christian Zechmann, F. Bruchertseifer, Uwe Haberkorn, and Clemens Kratochwil. "Contrast-enhanced Ultrasound Monitoring of Perfusion Changes in Hepatic Neuroendocrine Metastases After Systemic Versus Selective Arterial 177Lu/90Y-DOTATOC and 213Bi-DOTATOC Radiopeptide Therapy." Experimental Oncology 35, no. 2 (2013).

MLA (9th ed.) Citation

Giesel, Frederik L., et al. "Contrast-enhanced Ultrasound Monitoring of Perfusion Changes in Hepatic Neuroendocrine Metastases After Systemic Versus Selective Arterial 177Lu/90Y-DOTATOC and 213Bi-DOTATOC Radiopeptide Therapy." Experimental Oncology, vol. 35, no. 2, 2013.